The buyback price has been increased from ₹1,150/share to ₹1,260; the maximum number of equity shares proposed to be bought back has been reduced from 95.65 lakh to 87.30 lakh. Shares of Zydus Lifesciences Ltd ended at ₹1,085.95, up by ₹7, or 0.65%, on the BSE today, May 27.
